Screen LibraryAtherosclerosis : risks, mechanisms, therapies /
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of authors including...
Saved in:
| Group Author: | ; |
|---|---|
| Published: |
Wiley Blackwell,
|
| Publisher Address: | Hoboken, New Jersey : |
| Publication Dates: | [2014] |
| Literature type: | eBook |
| Language: | English |
| Subjects: | |
| Online Access: |
http://onlinelibrary.wiley.com/book/10.1002/9781118828533 |
| Summary: |
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of authors including leading physician-scientists, research experts and physicians, chapters are divided into four major sections, covering risk factors, cellular and molecular mechanisms, biochemical mechanisms and novel and future therapeutics. Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel The. |
| Carrier Form: | 1 online resource. |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781118828519 (ePub) 1118828518 (ePub) 9781118828557 (Adobe PDF) 1118828550 (Adobe PDF) 9781118828533 1118828534 1118285913 (cloth) 9781118285916 (cloth) |
| Index Number: | RD598 |
| CLC: | R654.2 |
| Contents: |
Title Page; Copyright Page; Contents; Contributors; Foreword; Preface; Section I Risk Factors: Old and New; Chapter 1 Lipoproteins; Brief History of Cholesterol and Atherosclerosis; Lipoproteins; LDL and Atherosclerosis; Triglyceride-Rich Lipoproteins and Atherosclerosis; HDL and Atherosclerosis; Summary; References; Chapter 2 Role of Dysglycemia in Atherosclerosis; Introduction; Molecular Mechanisms by Which Dysglycemia Accelerates Atherosclerosis; Dysglycemia and Endothelial Cells; Dysglycemia and Vascular Smooth Muscle Cells; Dysglycemia and Macrophages; Conclusion; Acknowledgments Mechanisms of Flow-Induced InflammationConclusions; References; Chapter 5 Homocysteine: A Controversial Cardiovascular Risk Factor; Introduction; Epidemiological Studies: Establishment of Homocysteine as a Risk Factor; Animal Models of Hyperhomocysteinemia; Clinical Intervention Trials; Summary and Perspectives; References; Chapter 6 Hypertension as a Risk Factor for Atherosclerosis; Introduction; Evidence Linking Atherosclerosis and Hypertension; Molecular and Cellular Mechanisms Linking Hypertension and Atherosclerosis; Implications for Treatment and Future Directions; References Chapter 7 The Genetics of Atherosclerosis: From Polymorphisms to PopulationsIntroduction; Lessons from Mendelian Diseases-Familial Hypercholesterolemia; Role for Genetic Diagnosis and Screening; Genetically Isolated Population Studies: Implications for Atherosclerosis in the General Population; GWAS to Identify Atherosclerosis Risk Genes in the General Population; Identification of a Risk Allele Located at 9P21 by GWAS; Technologic Advances and the Future; Conclusion; Acknowledgments; References; Chapter 8 Life Style; Introduction; Lifestyle Factors and Cardiovascular Disease Lifestyle Factors and Cardiovascular Disease in the YoungPhysical Activity; Diet and Nutrition; Environmental Effects; Ambient Air Pollution; Other Environmental Factors; Summary; References; Section II Cellular Mechanisms; Chapter 9 Endothelial Cells; Introduction; Endothelial Nitric Oxide; Flow and Arterial Shear Stress; Peroxisome Proliferator-Activated Receptor Nuclear Receptor Family; Endothelial Progenitor Cells; Future Directions; References; Chapter 10 Vascular Smooth Muscle Cells; Introduction; SMCS in Atheroma Progression; Extrinsic Control of SMC Biology |